Global Intranasal Drug Delivery Devices Market Growth 2023-2029
Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. Intranasal Drug Delivery Devices are medical devices used for drug delivery through noses.
LPI (LP Information)' newest research report, the “Intranasal Drug Delivery Devices Industry Forecast” looks at past sales and reviews total world Intranasal Drug Delivery Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Intranasal Drug Delivery Devices sales for 2023 through 2029. With Intranasal Drug Delivery Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intranasal Drug Delivery Devices industry.
This Insight Report provides a comprehensive analysis of the global Intranasal Drug Delivery Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intranasal Drug Delivery Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Intranasal Drug Delivery Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intranasal Drug Delivery Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intranasal Drug Delivery Devices.
The global Intranasal Drug Delivery Devices market size is projected to grow from US$ 1118.1 million in 2022 to US$ 2382.3 million in 2029; it is expected to grow at a CAGR of 2382.3 from 2023 to 2029.
North America is the largest region of Intranasal Drug Delivery Devices, with a market share about 40%. It was followed by Europe with 35%. BD, AptarGroup, 3M Company, Teleflex, H&T Presspart and Bespak are the top 6 manufacturers of industry, and they had about 85% combined market share.
This report presents a comprehensive overview, market shares, and growth opportunities of Intranasal Drug Delivery Devices market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Multidose
Uni/bidose
Segmentation by application
Personal Use
Hospital Use
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BD
AptarGroup
3M
Teleflex
H&T Presspart
Bespak
Key Questions Addressed in this Report
What is the 10-year outlook for the global Intranasal Drug Delivery Devices market?
What factors are driving Intranasal Drug Delivery Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Intranasal Drug Delivery Devices market opportunities vary by end market size?
How does Intranasal Drug Delivery Devices break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook